RIO DE JANEIRO, BRAZIL - The controversy over Coronavac's effectiveness following Covid-19 outbreaks in Chile, even with advanced vaccination, may be about to cool.
A study published Wednesday (7) in the New England Journal of Medicine shows that the vaccine had 86% effectiveness in preventing deaths from the disease in the Andean country. For the study, results were observed in 10.2 million people vaccinated with the two doses of Coronavac between Feb. 2 and May 1.
Read also: Check out our coverage on Chile
It . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here